Collegium Pharmaceutical Inc (COLL) earnings · $1.12B cap
These earnings events as JSON? API free 100/dayCollegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
This COLL earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported COLL revenue for 2026-06-30 was $199.9M. Net income was -$15.1M. Revenue was up 3.3% from 2026-03-31 to 2026-06-30. COLL currently screens at market cap $1.12B.
When the next COLL 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 3.3% from 2026-03-31 to 2026-06-30. An earnings headline that ignores that move is noise.
Not investment advice. Full COLL research stays on the stock page; the tape stays on the quote page.
COLL earnings FAQ
What are COLL's latest revenue and net income?
Latest cached Collegium Pharmaceutical Inc (COLL) revenue for Jun 30, 2026 was $199.9M. Net income was -$15.1M. Statements: https://lician.com/financials/coll
What is COLL's latest diluted EPS?
Latest cached Collegium Pharmaceutical Inc (COLL) diluted EPS for Jun 30, 2026 was -$0.46.
What period does the latest COLL earnings print cover?
The latest cached Collegium Pharmaceutical Inc (COLL) earnings print covers Jun 30, 2026. The prior cached period on this page is Mar 31, 2026.
How did COLL revenue change from the prior cached period?
Cached Collegium Pharmaceutical Inc (COLL) revenue was up 3.3% from $193.5M (Mar 31, 2026) to $199.9M (Jun 30, 2026). Statements: https://lician.com/financials/coll
Where are COLL earnings listed?
Cached earnings facts for Collegium Pharmaceutical Inc (COLL) are listed at https://lician.com/earnings/coll. Statements: https://lician.com/financials/coll
Not investment advice.